BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11459258)

  • 1. Duration of thrombosis prophylaxis in orthopaedic surgery.
    Finsen V
    Ann Chir Gynaecol; 2001; 90(2):105-8. PubMed ID: 11459258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombosis prophylaxis in orthopedic surgery].
    Finsen V
    Tidsskr Nor Laegeforen; 2000 Feb; 120(5):565-7. PubMed ID: 10833913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism after a total hip arthroplasty: prevention and treatment.
    Berry DJ
    Instr Course Lect; 2003; 52():275-80. PubMed ID: 12690855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolic prophylaxis following total hip arthroplasty: a North American perspective.
    Clark CR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):12-9. PubMed ID: 12349890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mortality rate after thromboembolism prophylaxis in the hip fracture surgery.
    Chotanaphuti T; Jareonarpornwatana A; Laoruengthana A
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S115-9. PubMed ID: 20120672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
    Verhaeghe R
    Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery.
    Paiement GD; Wessinger SJ; Harris WH
    Clin Orthop Relat Res; 1987 Oct; (223):188-93. PubMed ID: 3652574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
    Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of venous thromboembolic disease complications in primary hip arthroplasty patients.
    Paiement GD
    Instr Course Lect; 1998; 47():331-5. PubMed ID: 9571434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of thromboembolism in surgery of fractures of the upper end of the femur].
    Kudrna K; Krska Z; Kvasnicka J; Bríza J; Trca S
    Sb Lek; 2002; 103(2):203-12. PubMed ID: 12688143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the necessary time for prevention of thromboembolism using heparin/dihydroergotamine during implantation of partial hip joint endoprostheses].
    Maldini B; Matijasević B
    Acta Chir Iugosl; 1989; 36(1):169-78. PubMed ID: 2711804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.